Dopamine Hydrochloride Injection
Product Images NDC 51662-1489

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 51662-1489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of Dopamine Hydrochloride showing a benzene ring with two hydroxyl groups and an ethylamine chain with a hydrochloride salt.*

FDA Label Image

Dosage (Dosage)

A data table showing concentrations and volumes of dopamine hydrochloride injection. It compares dopamine hydrochloride concentrations of 40 mg/mL and 80 mg/mL across volumes of 5 mL and 10 mL, and lists corresponding microgram per milliliter concentrations for 250 mL, 500 mL, and 1000 mL bottles of intravenous solution.*

FDA Label Image

Vial Label (51662 1489 1 Vial Label)

Label for DOPamine Hydrochloride Injection, USP, 40 mg/mL (200 mg/5 mL) in a 5 mL single dose vial. The label includes a caution that the product must be diluted and is for intravenous use. It lists inactive ingredients like sodium metabisulfite, citric acid, and sodium citrate. Manufactured by Hikma Farmacêutica, Portugal, and distributed by West-Ward, Eatontown, NJ, USA.*

FDA Label Image

Rfid Label (51662 1489 1 Rfid Label)

The image shows a medical product label featuring a series of data matrix codes and alphanumeric strings including a GTIN and lot number. The label indicates distribution by HF Acquisitions Co., LLC in Mukilteo, WA 98275. It includes a note to see the manufacturer's insert for more information. No specific proprietary or strength details visible on this label.*

FDA Label Image

Pouch Labeling (51662 1489 2 Pouch)

Label for DOPAMINE HYDROCHLORIDE injection, USP, 200 mg/5 mL (40 mg/mL) in a 5 mL vial. The label includes NDC 51662-1489-2, lot number, expiration date of 2030-01-01, and states intravenous use only. Manufactured by HF Acquisition Co., LLC in Mukilteo, WA, with storage and usage cautions detailed. A barcode is visible at the bottom right.*

FDA Label Image

Vial Label (51662 1489 2 Vial)

Label for DOPamine Hydrochloride Injection USP 200 mg per 5 mL (40 mg/mL) in a 5 mL single dose vial. The label includes a caution that the product must be diluted and is for intravenous use. It lists stabilizers and buffer ingredients and identifies the manufacturer as Hikma Farmacêutica (Portugal), distributed by Hikma, Berkeley Heights, NJ.*

FDA Label Image

Case Labeling (51662 1489 3 Case)

Label for Dopamine Hydrochloride Injection USP, 200 mg/5 mL (40 mg/mL) in a 5 mL vial, packaging indicates case of 25. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Includes NDC 51662-1489-3 and lot number 123456, with expiration date 2030-01-01. Label notes intravenous use and dilution instructions, along with ingredients and storage conditions.*

FDA Label Image

Rfid Label (51662 1489 3 Rfid)

Partial label of DOPAMINE HYDROCHLORIDE injection, showing a white sticker with black text including barcode and numeric codes. The label references the distributor HF Acquisitions Co., LLC, Mukilteo, WA 98275, and includes a note to see the manufacturer's insert. The label is affixed on a plain, mostly blank surface.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.